Lycium Barbarum Polysaccharide Inhibits Ischemia-induced Autophagy by Promoting the Biogenesis of Neural Stem Cells-derived Extracellular Vesicles to Enhance the Delivery of MiR-133a-3p
Overview
Affiliations
Background: Neural stem cell-derived extracellular vesicles (NSC-EVs) mediated endogenous neurogenesis determines a crucial impact on spontaneous recovery after stroke. Here, we checked the influence of Lycium barbarum polysaccharide (LBP) on the biogenesis of NSC-EVs and then focused on studying mechanisms of LBP in ameliorating ischemic stroke outcome.
Methods: LBP was prepared to precondition NSCs and isolate EVs. MCAO models and primary NSCs were administrated to evaluate the therapeutic effect. RT-PCR, western blot, flow cytometry, and immunofluorescence techniques were performed to explore the mechanism.
Results: LBP pretreatment increased the production of NSC-EVs and improved the neuroprotective and recovery effects of NSC-EV in ischemic stroke mice. LBP-pretreated NSC-EV in a dose-dependent manner substantially reduced neuronal death compared with NSC-EV. Screening of the signaling cascade involved in the interaction between NSC-EV and neurons revealed that AMPK/mTOR signaling pathway inhibited autophagic activity in neurons receiving either treatment paradigm. NSC-EVs but not EVs collected from NSCs pretreated with the anti-miR-133a-3p oligonucleotide reduced cell death, whereas the anti-oligonucleotide promoted autophagy activity and cell death by modulating AMPK/mTOR signaling in OGD-induced primary neurons.
Conclusion: LBP activated AMPK/mTOR signaling pathway by increasing the enrichment and transfer of miR-133a-3p in NSC-EVs to inhibit stroke-induced autophagy activity.
Zhang Q, Wang Y, Zhu Z, Ahmed W, Zhou D, Chen L Int J Nanomedicine. 2025; 20:2253-2271.
PMID: 40007907 PMC: 11853779. DOI: 10.2147/IJN.S505792.
Xu K, Zhao X, He Y, Guo H, Zhang Y Front Pharmacol. 2024; 15:1481617.
PMID: 39508049 PMC: 11537945. DOI: 10.3389/fphar.2024.1481617.
Tang Z, Shu L, Cao Z, Xu Y, Li C Hum Cell. 2024; 37(6):1624-1637.
PMID: 39141224 DOI: 10.1007/s13577-024-01119-1.
Song J, Meng H, Deng G, Lin H Int J Nanomedicine. 2024; 19:7851-7870.
PMID: 39105098 PMC: 11299799. DOI: 10.2147/IJN.S460397.
Zhu Z, Zhang Q, Feng J, Zebaze Dongmo S, Zhang Q, Huang S Int J Nanomedicine. 2024; 19:4279-4295.
PMID: 38766658 PMC: 11102074. DOI: 10.2147/IJN.S451642.